The role of serum ischemia modified albumin level for the diagnosis of pulmonary thromboembolism

M. I. Inan, O. Deniz, E. Ucar, C. Tasci, S. Gumus, E. Tozkoparan, H. Yaman, H. Bilgic (Van, Ankara, Turkey)

Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism
Session: Pulmonary circulation: acute pulmonary tromboembolism
Session type: Thematic Poster Session
Number: 4115
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. I. Inan, O. Deniz, E. Ucar, C. Tasci, S. Gumus, E. Tozkoparan, H. Yaman, H. Bilgic (Van, Ankara, Turkey). The role of serum ischemia modified albumin level for the diagnosis of pulmonary thromboembolism. Eur Respir J 2013; 42: Suppl. 57, 4115

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Is serum cystatin C a predictor of acute pulmonary thromboembolism in patients with normal renal function?
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014


Prognostic role of serum bilirubin levels in pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016


Prognostic value of MRI in pulmonary arterial hypertension: Early and late predictors
Source: International Congress 2015 – Pulmonary hypertension: new pathophysiological insights
Year: 2015


The efficacy of CT in the detection of right ventricular dysfunction in acute pulmonary embolism and comparison with cardiac biomarkers
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015

Effect of serum NT-proBNP and H-FABP levels in predicting extent of acute pulmonary thromboembolism
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders
Year: 2010

Serum apelin 13 levels in patients with pulmonary embolism
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014


Classification of intermediate-risk pulmonary embolism patients with cardiac troponin and shock index
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016


Value of serum procalcitonin levels in the differential diagnosis of pneumonia and pulmonary embolism
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011

Prognostic value of Mastora obstruction score in acute pulmonary embolism
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016


The value of revised Geneva scoring system and D-dimer evaluation in the patients with suspicion of pulmonary embolism, admitted to the department of lung diseases
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015

The comparison of serum visfatin levels in patients with acute PTE and non-PTE independent of BMI
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015

Serum levels of microRNA-125a are decreased in patients with precapillary pulmonary hypertension and correlate inversely with hemodynamics
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

Assessment of inflammatory biomarkers and oxidative stress in pulmonary thromboembolism
Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism
Year: 2013

The role of procalcitonin (PCT) in differential diagnosis of pneumonia and pulmonary congestion associated with end-stage renal failure (ESRF)
Source: Annual Congress 2013 –Pneumonia and sepsis
Year: 2013


From CTPA-proven pulmonary embolism to patients clinical characteristics
Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism
Year: 2013


Prognostic value of TDI assessment of right ventricular function in patients with acute pulmonary embolism
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014


Leucocytes platelets co-aggregates remain elevated in patients with perfusion defects after pulmonary embolism
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016


Integration of the level of D-dimer (D-d) with Wells criteria to improve the prediction of pulmonary embolism (PE) before CT angiography of the lung (CTAL)
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014


Clinical usefulness and prognostic value of elevated cardiac troponin I levels in acute pulmonary embolism
Source: Eur Respir J 2004; 24: Suppl. 48, 277s
Year: 2004